IRIS
POZZI, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.080
EU - Europa 3.631
AS - Asia 3.391
SA - Sud America 549
AF - Africa 271
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 5
Totale 13.944
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.946
SG - Singapore 1.211
IT - Italia 957
VN - Vietnam 717
CN - Cina 574
RU - Federazione Russa 533
BR - Brasile 436
UA - Ucraina 382
HK - Hong Kong 334
DE - Germania 297
FR - Francia 254
IE - Irlanda 245
FI - Finlandia 226
SE - Svezia 219
CI - Costa d'Avorio 159
DK - Danimarca 140
TR - Turchia 133
GB - Regno Unito 121
IN - India 101
KR - Corea 84
NL - Olanda 78
CA - Canada 60
BD - Bangladesh 52
AT - Austria 51
ZA - Sudafrica 47
AR - Argentina 40
MX - Messico 40
MA - Marocco 29
PL - Polonia 28
ES - Italia 26
IQ - Iraq 22
ID - Indonesia 21
JP - Giappone 21
EC - Ecuador 20
AU - Australia 16
RO - Romania 16
PH - Filippine 15
VE - Venezuela 15
BE - Belgio 13
PK - Pakistan 13
UZ - Uzbekistan 13
LT - Lituania 12
CO - Colombia 11
CL - Cile 10
TH - Thailandia 10
SA - Arabia Saudita 9
CR - Costa Rica 8
JM - Giamaica 7
EG - Egitto 6
JO - Giordania 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
AZ - Azerbaigian 5
DZ - Algeria 5
HR - Croazia 5
IL - Israele 5
PY - Paraguay 5
TN - Tunisia 5
EU - Europa 4
LB - Libano 4
MY - Malesia 4
PA - Panama 4
PE - Perù 4
RS - Serbia 4
TW - Taiwan 4
UY - Uruguay 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
GE - Georgia 3
HN - Honduras 3
KW - Kuwait 3
KZ - Kazakistan 3
MD - Moldavia 3
NP - Nepal 3
OM - Oman 3
SY - Repubblica araba siriana 3
AO - Angola 2
BB - Barbados 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
GY - Guiana 2
KG - Kirghizistan 2
LC - Santa Lucia 2
PT - Portogallo 2
SM - San Marino 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BW - Botswana 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
GA - Gabon 1
GT - Guatemala 1
HU - Ungheria 1
Totale 13.926
Salva come PNG Salva come JPEG
Città #
Ashburn 890
Singapore 742
Dallas 703
Chandler 422
Jacksonville 382
San Jose 331
Hong Kong 322
Dublin 240
Boardman 235
Ho Chi Minh City 222
Fairfield 204
New York 187
Hanoi 166
Abidjan 159
Wilmington 151
Los Angeles 137
Beijing 126
The Dalles 121
Helsinki 117
Marche 113
Council Bluffs 104
Des Moines 99
Lauterbourg 99
Houston 87
Moscow 85
Lawrence 84
Princeton 83
Seattle 83
San Mateo 80
Munich 74
Ancona 73
Ann Arbor 69
Milan 69
Orem 63
Woodbridge 62
Hefei 60
Cambridge 59
Turin 53
Buffalo 44
Da Nang 44
Turku 39
Chennai 38
Centro 37
Chicago 36
Haiphong 36
San Diego 36
São Paulo 36
Vienna 34
Amsterdam 29
Johannesburg 29
Shanghai 27
Tolentino 27
London 26
Recanati 26
Rome 25
Montreal 24
Stockholm 23
Brooklyn 22
Nuremberg 21
Santa Clara 20
Washington 20
Wuhan 20
Denver 19
Tokyo 18
Mexico City 17
Warsaw 17
Atlanta 16
Redmond 16
Ankara 15
Berlin 15
Boston 15
Manchester 15
Aversa 14
Guangzhou 14
Poplar 14
Belo Horizonte 13
Brussels 13
Curitiba 13
Pavia 13
Brasov 12
Frankfurt am Main 12
Biên Hòa 11
Hải Dương 11
Phoenix 11
Quito 11
Rio de Janeiro 11
San Francisco 11
Tashkent 11
Civitanova Marche 10
Mumbai 10
Naples 10
Pune 10
Salt Lake City 10
Wuxi 10
Baghdad 9
Delhi 9
Istanbul 9
New Delhi 9
Paris 9
Toronto 9
Totale 8.547
Salva come PNG Salva come JPEG
Nome #
Cancer stem cell enrichment is associated with enhancement of nicotinamide N-methyltransferase expression 215
Bladder Cancer Chemosensitivity is Affected by Paraoxonase-2 Expression 203
Paraoxonase-2 in osteosarcoma: potential for the development of a targeted anticancer therapy 190
Clinical performance and utility of a NNMT-based urine test for bladder cancer 181
Inflammatory cytokines patterns in the placenta of pregnancies complicated by HELLP syndrome. 177
Differential expression of nicotinamide N-methyltransferase in primary and recurrent ameloblastomas and odontogenic keratocysts 176
Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma 175
Aspetti infiammatori, trombotici e immunitari nella biologia dell’aborto spontaneo ricorrente. 170
Deepening Cisplatin sensitivity on Oral Squamous cell Carcinoma cell lines after PON2 knockdown: A FTIRM investigation 169
Paraoxonase-2 shRNA-mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines 168
Betacyanins enhance vitexin-2-O-xyloside mediated inhibition of proliferation of T24 bladder cancer cells 168
Role Played by Paraoxonase-2 Enzyme in Cell Viability, Proliferation and Sensitivity to Chemotherapy of Oral Squamous Cell Carcinoma Cell Lines 164
Curcumin and its Analogues in Oral Squamous Cell Carcinoma: State-of-the-art and Therapeutic Potential 163
Analysis of tissue and salivary nicotinamide N-methyltransferase in oral squamous cell carcinoma: basis for the development of a noninvasive diagnostic test for early-stage disease. 160
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 160
RNA-Mediated Gene Silencing of Nicotinamide N-Methyltransferase Is Associated with Decreased Tumorigenicity in Human Oral Carcinoma Cells. 159
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 159
Expression and prognostic significance of apoptotic genes in oral squamous cell carcinoma 158
Espressione della trombomodulina placentare negli aborti spontanei ricorrenti. 155
Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma. 155
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 155
Apoptosis pathway is involved in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome and intrauterine growth restriction (IUGR). 154
Association of miR-126 with soluble mesothelin-related peptides: a novel marker for malignant mesothelioma. 152
Involvement of the oral cavity in psoriasis: results of a clinical study 152
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 151
Exploring the role of paraoxonase-2 in bladder cancer: analyses performed on tissue samples, urines and cell cultures 149
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 149
Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance 147
Clues to apoptosis pathway involvement in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome and intrauterine growth restriction (IUGR). 145
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies 143
Nicotinamide N-methyltransferase in Non-small Cell Lung Cancer: Promising Results for Targeted Anti-cancer Therapy. 142
Epithelial Biological Response to Machined Titanium vs. PVD Zirconium-Coated Titanium: An In Vitro Study 141
FTIRM analyses as a tool to explore cisplatin sensitivity of oral squamous cell carcinoma cell lines after PON2 knockdown 140
Inflammatory cytokines pattern in recurrent miscarriage. 139
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 139
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 138
L'enzima nicotinamide N-Metiltrasferasi: un nuovo marker diagnostico e target terapeutico nel carcinoma orale 135
Fattore di differenziamento eritrocitario (EDRF) nella patologia ostetrica. 134
The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update 133
Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes 132
Expression of extracellular matrix and adhesion proteins in pelvic organ prolapse 132
Treatment of osteosarcoma and Merkel cell carcinoma cell lines with inhibitors of nicotinamide N-methyltransferase: potential for the development of targeted therapeutic strategy 130
Enhancing cisplatin efficacy in triple-negative breast cancer through pon2 silencing: insights from FTIRM analysis 128
Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test. 128
Identification and Characterization of Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma Cell Lines 128
Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration and chemoresistance of Merkel cell carcinoma cells in vitro 125
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 125
Paraoxonase-2 expression in oral squamous cell carcinoma 125
Cancer stem cells from human tumor cell lines: molecular and phenotypic features 124
Targeting nicotinamide N-methyltransferase decreased aggressiveness of osteosarcoma cells 123
CSCs selection, characterization and tumorigenic potential in OSCC. 122
Inflammatory cytokines pattern in recurrent miscarriage. 121
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 120
Pattern di espressione placentare delle citochine infiammatorie nella HELLP syndrome. 119
Salivary and tissue Nicotinamide N-methyltrasferase: potential use for early and non-invasive diagnosis of oral squamous cell carcinoma. 118
Nicotinamide N-methyltransferase, a promising marker for human osteosarcoma 117
RNA-mediated gene silencing NNMT decreases tumorigenity in OSCC cells. 117
Inflammatory cytokines patterns in the placenta of pregnancies complicated by Hellp syndrome. 116
Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression. 116
The involvement of inflammatory cytokines in the pathogenesis of recurrent miscarriage. 116
Enhanced expression of nicotinamide N-methyltransferase in non-small cell lung cancer: potential for the development of a targeted anticancer therapy. 116
Role of nicotinamide N-methyltransferase in non-small cell lung cancer: in vitro effect of shRNA-mediated gene silencing on tumorigenicity 116
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 115
FTIR Imaging as a new tool for investigating oral tongue squamous cell carcinoma 114
Identification and characterization of cancer stem cells from Head and Neck squamous cell carcinoma cell line Hep-2. 114
Molecular and phenotypic characterization of cancer stem cells from human tumor cell lines 114
Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis. 113
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 113
Catechol-o-methyltransferase, a promising diagnostic marker for non-invasive detection of human urothelial carcinoma 111
Catecholamine O-Methyltransferase as a Promising Diagnostic and Therapeutic Target in Oral Squamous Cell Carcinoma 111
Enhanced expression of amyloid precursor protein in platelets from patients with Alzheimer’s disease and frontotemporal lobar degeneration. 111
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 111
Evaluation of urinary Nicotinamide N-methyltransferase: a non-invasive diagnostic test for bladder cancer 109
Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms 108
Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review 108
Nicotinamide N-methyltransferase: a promising marker for oral cancer. 104
RNA-mediated gene silencing of nicotinamide N-methyltransferase is associated with decreased tumorigenicity in human oral carcinoma cells. 104
Characterization of cancer stem cells from larynx and bladder carcinoma cell lines 103
Structural Basis of Substrate Recognition in Human Nicotinamide N-Methyltransferase. 102
Nicotinamide N-methyltransferase as potential diagnostic marker in patients with urinary bladder carcinoma: a real-time approach. 102
Natural extracts from the genus Beta and their cytotoxic activity on T24 human bladder cancer cells 102
Quantitative analysis of Nicotinamide N-methyltransferase expression in urine and tumour tissue of bladder cancer patients and its potential relevance for disease detection. 101
Micro-RNA profiling identifies mir-126 as promising biomarker for prognosis and early detection of malignant mesothelioma. 101
Enhanced expression of paraoxonase 2 in human bladder cancer 101
Paraoxonase 2 (PON2) expression in bladder cancer 96
Enhanced expression of nicotinamide N-methyltransferase in human osteosarcoma: potential role in tumor growth and chemoresistance 95
Nicotinamide n-methyltransferase: a new diagnostic marker and therapeutic target for oral carcinoma. 95
Nicotinamide N-methyltransferase: a potential target molecule for effective therapy and early diagnosis of oral squamous cell carcinoma. 94
Enzymes Dysregulation in Cancer: From Diagnosis to Therapeutical Approaches 93
Espressione di Pokemon nel carcinoma orale. 92
Nicotinamide N-methyltransferase as effective diagnostic tool and promising therapeutic target for oral cancer. 92
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 92
FTIRM: an analytical approach to test the effectiveness of cisplatin treatment on PON2 silenced otscc cells 92
Inflammatory cytokines and receptors in placentas from pregnancies complicated by HELLP syndrome. 90
Profilo dell’espressione dei geni coinvolti nel pathway dell’apoptosi nel carcinoma orale. 90
Nicotinamide N-Methyltransferase: a promising biomarker for early diagnosis and prognostic monitoring of oral squamous cell carcinoma. 89
Urinary Cell-Free DNA as a potential diagnostic biomarker for bladder cancer in older adults 88
Nicotinamide N-methyltransferase, a promising marker for human Merkel cell carcinoma 87
Nicotinamide N-Methyltransferase as potential predictor of lymph node metastasis in Oral Squamous Cell Carcinoma. 87
Role of paraoxonase-2 in triple-negative breast cancer: effect of shRNA-mediated gene silencing on cell proliferation and chemosensitivity 86
Totale 12.807
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.245
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 0 0 0 0 0 0 33
2021/2022628 29 167 14 23 0 19 23 59 33 60 49 152
2022/20231.409 100 170 101 119 83 194 18 88 336 13 121 66
2023/20241.136 169 26 82 126 145 183 14 34 20 90 52 195
2024/20252.146 287 144 101 46 108 30 185 74 400 153 251 367
2025/20266.543 540 382 734 658 711 433 1.129 555 531 541 185 144
Totale 14.281